Align Technology | ALGN - Gewinn Vor Steuern

Aktienkurs
178.64
Täglich Wechseln
1.36 0.77%
Monatlich
7.45%
Jährlich
3.08%
Q2 Prognose
185.55




Gewinn Vor Steuern Veränderung Datum
3M USD 878M 119M 2026-03
Align Technology USD 176.6M 81.86M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bruker USD -72.6M 73.1M 2025-09
Cardinal Health USD 598M 214M 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Cooper Companies USD 116.8M 137.4M 2025-09
CVS Health USD 1.35B 4.84B 2025-12
Danaher USD 1.24B 138M 2026-03
Dentsply International USD -230M 77M 2025-09
Dexcom USD 300M 58.9M 2025-09
Henry Schein USD 137M 16M 2025-09
Idexx Laboratories USD 306.98M 37.79M 2025-12
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
IQVIA Holdings USD 537M 5.62B 2025-12
Masimo USD 74.9M 19.5M 2025-09
McKesson USD 1.4B 344M 2025-09
Mettler Toledo International USD 269.24M 20.58M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Solventum Corp USD 511M 149M 2025-09
Stryker USD 1.03B 13M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Veeva Systems USD 436.85M 14.82M 2025-09
Waters USD 170.12M 7.57M 2025-09
Zimmer Biomet Holdings USD 98M 320.7M 2025-12
Zoetis USD 887M 15M 2025-09